// App-Quantinova.ai

e23097 : Utility of liquid biopsies to assess circulating tumor DNA in patients with lung adenocarcinoma.

Researchers

Presenter

  • Maria Clemence Schwaederle

Principal Investigators

  • Sandip Pravin Patel

  • Hatim Husain

  • Megumi Ikeda

  • Richard Burnham Lanman

  • Kimberly C. Banks

  • Amirali Talasaz

  • Lyudmila Bazhenova

  • Razelle Kurzrock

Medical Centers

  • Center for Personalized Cancer Therapy, UCSD Moores Cancer Center, La Jolla, CA

  • Center for Personalized Cancer Therapy and Division of Hematology and Oncology, UCSD Moores Cancer Center, La Jolla, San Diego, CA

  • Guardant Health, Rewdwood City, CA

  • University of California, San Diego, La Jolla, CA

Locations

  • United States

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Lung Cancer

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved